Prokidney Corp.
About
Prokidney Corp. (NASDAQ:PROK) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 25 2026
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Mar 18 2026
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Jan 6 2026
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 10 2025
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Nov 6 2025
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Financials
Revenue
$893 K
Market Cap
$551.25 M
EPS
-0.53